Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy.

Mitochondria play a crucial part in the cell's ability to adapt to the changing microenvironments and their dysfunction is associated with an extensive array of illnesses, including cancer. Mitochondrial dysfunction has been identified as a potential therapeutic target for cancer therapy. The objective of this article is to give an in-depth analysis of cancer treatment that targets the mitochondrial genome at the molecular level. Recent studies provide insights into nanomedicine techniques and theranostic nanomedicine for mitochondrial targeting. It also provides conceptual information on mitochondrial biomarkers for cancer treatment. Major drawbacks and challenges involved in mitochondrial targeting for advanced cancer therapy have also been discussed. There is a lot of evidence and reason to support using nanomedicine to focus on mitochondrial function. The development of a delivery system with increased selectivity and effectiveness is a prerequisite for a theranostic approach to cancer treatment. If given in large amounts, several new cancer-fighting medicines have been created that are toxic to healthy cells as well. For effective therapy, a new drug must be developed rather than an old one. When it comes to mitochondrial targeting therapy, theranostic techniques offer valuable insight.

Epileptic Seizure Recognition Using Reduced Deep Convolutional Stack Autoencoder and Improved Kernel RVFLN From EEG Signals.

In this paper, reduced deep convolutional stack autoencoder (RDCSAE) and improved kernel random vector functional link network (IKRVFLN) are combined to recognize the epileptic seizure using both the multichannel scalp and single-channel electroencephalogram (EEG) signals. The novel RDCSAE structure is designed to extract the most discriminative unsupervised features from EEG signals and fed into the proposed supervised IKRVFLN classifier to train efficiently by reducing the mean-square error cost function for recognizing the epileptic seizure activity with promising accuracy. The proposed RDCSAE-IKRVFLN algorithm is tested over the benchmark Boston Children's Hospital multichannel scalp EEG (sEEG) and Boon University, Germany single-channel EEG databases. The less computational complexity, higher learning speed, better model generalization, accurate epileptic seizure recognition, remarkable classification accuracy, negligible false positive rate per hour (FPR/h) and short event recognition time are the main advantages of the proposed RDCSAE-IKRVFLN method over reduced deep convolutional neural network (RDCNN), RDCSAE and RDCSAE-KRVFLN methods. The proposed RDCSAE-IKRVFLN method is implemented in a high-speed reconfigurable field-programmable gate array (FPGA) hardware environment to design a computer-aided-diagnosis (CAD) system for automatic epileptic seizure diagnosis. The simplicity, feasibility, and practicability of the proposed method validate the stable and reliable performances of epilepsy detection and recognition.

Multifuse multilayer multikernel RVFLN+ of process modes decomposition and approximate entropy data from iEEG/sEEG signals for epileptic seizure recognition.

In this paper, the extracted features using variational mode decomposition (VMD) and approximate entropy (ApEn) privileged information of the input EEG signals are combined with multilayer multikernel random vector functional link network plus (MMRVFLN+) classifier to recognize the epileptic seizure epochs efficaciously. In our experiment Bonn University single-channel intracranial electroencephalogram (iEEG) and Children's Hospital Boston-Massachusetts Institute of Technology (CHB-MIT) multichannel scalp EEG (sEEG) recordings are considered to evaluate the efficacy of the proposed method. The VMD is applied on chaotic, non-stationary, nonlinear, and complex EEG signal to decompose it into three band-limited intrinsic mode functions (BLIMFs). The Hilbert transform (HT) is applied on BLIMFs to extract informative spectral and temporal features. The ApEn is computed from the raw EEG signals as the privileged information and given to the multi-hidden layer structure to obtain the most discriminative compressed form. The scatter plots show the distinct nature of compressed privileged ApEn information among the seizure pattern classes. The linear as well as nonlinear mapping, local and global kernel function, high-learning speed, less computationally complex MMRVFLN+ classifier is proposed to recognize the seizure events accurately by importing the efficacious features with ApEn as the input. The advanced signal processing algorithm i.e., Hilbert Huang transform (HHT) with ApEn and MMRVFLN+ are combined to compare the performance with the proposed VMDHTApEn-MMRVFLN+ method. The proposed method has remarkable recognition ability, superior classification accuracy, and excellent overall performance as compared to other methods. The digital architecture of the multifuse MMRVFLN+ is developed and implemented on a high-speed reconfigurable FPGA hardware platform to validate the effectiveness of the proposed method. The superior classification accuracy, the negligible false positive rate per hour (FPR/h), simplicity, feasibility, robustness, and practicability of the proposed method validate its ability to recognize the epileptic seizure epochs automatically.